Autoimmune Conditions

The diverse range of autoimmune conditions amenable to stem cell treatments vary from rheumatoid arthritis, polymyalgia rheumatica to sarcoidosis and multiple sclerosis. Within the autoimmune camp it is recognised the pathology is an inflammatory destruction of your “own self`” due to an immune mediated reaction that your own body recognises its tissue as ‘foreign’.

Pathologically there is vasculitis, inflammatory cell infiltrates and destruction of normal tissue. The reason for this reaction is essentially unknown but theories abound including viral, genetic and ‘auto-immune’ in nature.

The role of stem cells includes attraction to damaged tissue and the response is one of tissue repair and regeneration. Additionally the stem cells reduce the vasculitis and inhibit the complementary cascade of inflammatory mediators modulating and reducing inflammation and damage.

The use of drugs and biologics are yet another excellent mechanism to reduce symptoms, however some of these drugs may have moderate to severe side effects. By suppressing the immune system there may be associated risks such as cancer or tuberculosis. For every benefit of use of these drugs then there may be complementary down sides.

It is known that stem cells, being autologous and recognised by ‘self’ gravitate to the site of injury and are programmed to repair tissue in a different way to inflammatory suppressors. The very nature of being native to the patients body (autologous) minimises the development of further adverse reactions.

While recognise and agree with conventional autoimmune therapy there are some patients where this therapy is contra indicated, fails to work or is associated with significant side effects.

We support the concept that mesenchymal stem cells have an important role to play with significantly less side effects.

At we pride ourselves on ensuring patients know the team diagnosing and conducting their stem cell therapy. Professor Russell Vickers is the lead specialist, working within a team of specialist surgeons and doctors.

Important questions that patients should ask of any treating clinicians and facility:

  • Are my treating doctors specialist surgeons/doctors and stem cell experts?
  • How many publications and research based studies have they published in peer reviewed journals?
  • Can they augment stem cell therapy with the known benefits of adjunctive therapy? is Europes premier stem cell organisation guided by evidence based medicine and clinical research.

Our founding director, Professor Russell Vickers PhD, MDsc, M Med, MA, FFPM (ANZCA) is an Australian and New Zealand board registered surgeon with over 100 publications, books and thousands of invited lectures and presentations on stem cells, pain, peptide synthesis and biochemistry. Professor Vickers is the leader of a family team of surgeons assisting him including Dr Peter Vickers, MD, FRCS (Edinburgh), FRACDS, Dr Richard Vickers, MD, FRCS (England, Glasgow, Ireland), FRACDS (OMS) and Dr Jessica Vickers, MD, MCOM, BA/BN as co-ordinator.

This medical summary has been written by Professor Vickers and his family team of specialist consultants.

It has been written by medically qualified writers.

Other Diseases We Treat


Pathology: Dementia is a condition characterised by progressive or persistent loss of intellectual functioning, especially with impairment of memory and abstract Continue Reading

Read More

Trigeminal Neuralgia

Pathology: Trigeminal Neuralgia is a debilitating pain affecting the distribution of one or more of the branches of the Trigeminal nerve. Continue Reading

Read More

Cosmetic Stem Cells for the Face

Pathology:  Facial structure undergoes the ageing process like all tissues. The structure is composed of bone and soft tissue which Continue Reading

Read More



Get an online consultation with one of our doctors that specialize in stem cell therapy to help you assess if this type of treatment can help with your condition